DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by VandenBranden, M.
Right arrow Articles by Jensen, C. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by VandenBranden, M.
Right arrow Articles by Jensen, C. B.

Vol. 26, Issue 11, 1063-1068, November 1998

Alterations of the Catalytic Activities of Drug-Metabolizing Enzymes in Cultures of Human Liver Slices

Mark VandenBranden, Steven A. Wrighton, Sean Ekins, Jennifer S. Gillespie, Shelly N. Binkley, Barbara J. Ring, Melinda G. Gadberry, D. Charlene Mullins, Stephen C. Strom, and Charles B. Jensen

Department of Drug Disposition, Lilly Research Laboratories, Eli Lilly and Co. (M.V., S.A.W., S.E., J.S.G., S.N.B., B.J.R., M.G.G., D.C.M., C.B.J.), and Department of Pathology, University of Pittsburgh (S.C.S.)

Precision-cut human liver slices are an important tool for defining the metabolism and hepatotoxicity of drug candidates early in development. Because of the frequent use of this in vitro tool, a knowledge of the catalytic activities of the drug-metabolizing enzymes during human liver slice culture is necessary. Therefore, marker catalytic activities for various cytochrome P450 (P450 or CYP) forms, as well as phase II activities (glucuronidation and sulfation of 7-hydroxycoumarin), were measured in slices from three different human livers during 96 hr in culture. Standard viability measures were found to be stable from 8 to 24 hr and then declined to 96 hr. Catalytic activities measured for the P450s were ethoxyresorufin O-deethylase (CYP1A2), coumarin 7-hydroxylase (CYP2A6), (S)-mephenytoin N-demethylase (CYP2B6), diclofenac 4'-hydroxylase (CYP2C9), (S)-mephenytoin 4'-hydroxylase (CYP2C19), bufuralol 1'-hydroxylase (CYP2D6), chlorzoxazone 6-hydroxylase (CYP2E1), and midazolam 1'-hydroxylase (CYP3A). The P450 activities decreased by approximately 20% by 4 hr and by at least 65% by 24 hr and were not measurable by 96 hr. In contrast to the phase I activities, 7-hydroxycoumarin glucuronosyltransferase activity was increased at the 8-hr time point by approximately 100% and then decreased to approximately initial values by 96 hr. The 7-hydroxycoumarin sulfotransferase activity of the slices decreased significantly more slowly than did the P450 activities. In conclusion, using conventional methods of liver slice preparation and culture, most of the metabolic capabilities of human liver slices are rapidly lost with time. Therefore, the development of culture methods for human liver slices that can improve the preservation of the drug-metabolizing capabilities may be required.

Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
P. Yi, C. E. Hadden, W. F. Annes, D. A. Jackson, B. C. Peterson, T. A. Gillespie, and J. T. Johnson
The Disposition and Metabolism of Naveglitazar, a Peroxisome Proliferator-Activated Receptor {alpha}-{gamma} Dual, {gamma}-Dominant Agonist in Mice, Rats, and Monkeys
Drug Metab. Dispos., January 1, 2007; 35(1): 51 - 61.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
I. A. M. de Graaf, R. de Kanter, M. H. de Jager, R. Camacho, E. Langenkamp, E. G. van de Kerkhof, and G. M. M. Groothuis
EMPIRICAL VALIDATION OF A RAT IN VITRO ORGAN SLICE MODEL AS A TOOL FOR IN VIVO CLEARANCE PREDICTION
Drug Metab. Dispos., April 1, 2006; 34(4): 591 - 599.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
M. B. Fisher, D. Jackson, A. Kaerner, S. A. Wrighton, and A. G. Borel
Characterization by Liquid Chromatography-Nuclear Magnetic Resonance Spectroscopy and Liquid Chromatography-Mass Spectrometry of Two Coupled Oxidative-Conjugative Metabolic Pathways for 7-Ethoxycoumarin in Human Liver Microsomes Treated with Alamethicin
Drug Metab. Dispos., March 1, 2002; 30(3): 270 - 275.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
S. Thohan, M. C. Zurich, H. Chung, M. Weiner, A. S. Kane, and G. M. Rosen
Tissue Slices Revisited: Evaluation and Development of a Short-Term Incubation for Integrated Drug Metabolism
Drug Metab. Dispos., October 1, 2001; 29(10): 1337 - 1342.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. Ekins and R. S. Obach
Three-Dimensional Quantitative Structure Activity Relationship Computational Approaches for Prediction of Human In Vitro Intrinsic Clearance
J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 463 - 473.
[Abstract] [Full Text]

Home page
 Drug Metab. Dispos.Home page
A. B. Renwick, P. S. Watts, R. J. Edwards, P. T. Barton, I. Guyonnet, R. J. Price, J. M. Tredger, O. Pelkonen, A. R. Boobis, and B. G. Lake
Differential Maintenance of Cytochrome P450 Enzymes in Cultured Precision-Cut Human Liver Slices
Drug Metab. Dispos., October 1, 2000; 28(10): 1202 - 1209.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics.